Journal for ImmunoTherapy of Cancer (Nov 2020)
431 Prospective, randomized trial of the tumor lysate, particle only vaccine compared to the tumor lysate, particle-loaded, dendritic cell vaccine to prevent recurrence for resected stage III/IV melanoma
Abstract
No abstracts available.